Comparing the effectiveness of different vaccination regimens using Sinovac and BNT162b2 vaccines among hospitalised patients: A single-centre hospital-based retrospective cohort study
| dc.contributor.author | Turan, Atakan | |
| dc.contributor.author | Öğüt, Hamdi | |
| dc.contributor.author | Varol, Aylin Ayyıldız | |
| dc.contributor.author | Koca, Nizameddin | |
| dc.contributor.author | Bozkurt, Hayri | |
| dc.date.accessioned | 2026-02-08T15:08:14Z | |
| dc.date.available | 2026-02-08T15:08:14Z | |
| dc.date.issued | 2025 | |
| dc.department | Bursa Teknik Üniversitesi | |
| dc.description.abstract | Objectives: This study aimed to assess the effectiveness of different vaccination regimens using two distinct SARS-CoV-2 vaccines against mortality risk and the need for intensive care unit (ICU) admission among hospitalised patients. Methods: The single-centre hospital-based retrospective cohort study was performed with adult COVID-19 patients in a tertiary-level hospital between March 2020 and September 2022. The associations between patients’ demographics and clinical features, vaccine status and regimens, in-hospital mortality, and need for ICU admission were evaluated using multivariable regression analyses. Results: During the study period, 2,373 patients were included. Mortality among unvaccinated patients was 85.0%, which was significantly lower in vaccinated groups (P<0.001), particularly with BNT162b2 than with Sinovac. Vaccination reduced mortality and ICU admission rates, with higher efficacy observed with increased vaccine doses and BNT162b2 regimens. Multivariable analyses confirmed age as a significant determinant and various vaccination schedules showed consistent reductions in mortality and ICU admissions. Conclusions: A two-dose initial plus one or more-dose booster BNT162b2 regimen effectively reduced mortality risks and ICU admission. | |
| dc.identifier.doi | 10.18621/eurj.1632009 | |
| dc.identifier.endpage | 1175 | |
| dc.identifier.issn | 2149-3189 | |
| dc.identifier.issue | 6 | |
| dc.identifier.startpage | 1167 | |
| dc.identifier.trdizinid | 1356946 | |
| dc.identifier.uri | https://doi.org/10.18621/eurj.1632009 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12885/4858 | |
| dc.identifier.volume | 11 | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | |
| dc.relation.ispartof | The European Research Journal | |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_TR-Dizin_20260207 | |
| dc.subject | COVID-19 | |
| dc.subject | mortality | |
| dc.subject | intensive care unit | |
| dc.subject | vaccine | |
| dc.title | Comparing the effectiveness of different vaccination regimens using Sinovac and BNT162b2 vaccines among hospitalised patients: A single-centre hospital-based retrospective cohort study | |
| dc.type | Article |












